An Israeli study finds that the Pfizer–BioNTech vaccine may be less effective against the South African variant when compared to other strains of the virus.
An Israeli study finds that the Pfizer–BioNTech vaccine may be less effective against the South African variant compared to other strains.
An Israeli study finds that the Pfizer–BioNTech vaccine may be less effective against the South African variant whencompared to other strainsofthevirus.